Pure Global

"Kabi" Fenwal Glycerolyte 57 Solution (non-sterile) - Taiwan Registration 59c7990e07e97805026a701f3031a0ac

Access comprehensive regulatory information for "Kabi" Fenwal Glycerolyte 57 Solution (non-sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 59c7990e07e97805026a701f3031a0ac and manufactured by BAXTER HEALTHCARE CORPORATION. The authorized representative in Taiwan is FRESENIUS KABI TAIWAN LIMITED.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
59c7990e07e97805026a701f3031a0ac
Registration Details
Taiwan FDA Registration: 59c7990e07e97805026a701f3031a0ac
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"Kabi" Fenwal Glycerolyte 57 Solution (non-sterile)
TW: "ๅกๆฏ”" ๆฃปๆฒƒ็”˜ๆฒนๆบถๆถฒ(ๆœชๆป…่Œ)
Risk Class 1
MD

Registration Details

59c7990e07e97805026a701f3031a0ac

Ministry of Health Medical Device Import No. 014240

DHA09401424006

Company Information

United States

Product Details

Limited to the first level identification range of cell cryogenic equipment and reactants (B.9225) for in vitro diagnosis of medical device management methods.

B Hematology and pathology devices

B9225 Cell cryogenic equipment and reactants for in vitro diagnostics

Imported from abroad

Dates and Status

Jun 12, 2014

Jun 12, 2024